help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 29, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1664
A more recent version of this article appeared on February 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/2/546    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Norata, G. D.
Right arrow Articles by Catapano, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Norata, G. D.
Right arrow Articles by Catapano, A. L.

Submitted on July 25, 2005
Accepted on November 21, 2005

Dihydrotestosterone decreases tumor necrosis factor {alpha} and lipopolysaccharide induced inflammatory response in human endothelial cells

Giuseppe Danilo Norata*, Gianpaolo Tibolla, Paul Maria Seccomandi, Angelo Poletti, and Alberico Luigi Catapano

Department of Pharmacological Sciences, University of Milan, Italy; Institute of Endocrinology, Centre of Excellence on Neurodegenerative Diseases, University of Milan, Milan, Italy; Center for the Prevention and therapy of Global cardiovascular risk, Italian Society for the Study of Atherosclerosis, Bassini Hospital, Cinisello Balsamo, Italy

* To whom correspondence should be addressed. E-mail: Danilo.Norata{at}unimi.it.

Context. An increasing body of evidence suggests that testosterone may exert beneficial effects on the development of atherosclerosis. It was suggested that testosterone may act after conversion into estradiol and activation of the estrogen receptors, however a direct role of androgens on the vascular wall has been proposed.

Objective. We investigated the effects of dihydrotestosterone on the pro-inflammatory response observed in human endothelial cells.

Design. Human endothelial cells isolated from umbilical cords were incubated with LPS or TNF{alpha} in the presence or absence of DHT. mRNA and cellular proteins were processed for gene expression studies, transient transfection experiments were performed to investigate molecular mechanisms involved in the effects observed.

Setting. These studies took place at the Department of Pharmacological Sciences, University of Milan, Italy.

Results. LPS and TNF{alpha} induced VCAM-1, and ICAM-1 mRNA and protein expression, as detected by Q-real time PCR, FACS and confocal microscopy, but this effect was reverted when cells were incubated with DHT. In addition DHT inhibited mRNA expression of IL-6, MCP-1, CD40, TLR4, PAI-1 and Cox-2 and the release of cytokines and chemokines as GRO, GM-CSF and TNF. The DHT effect was counteracted by bicalutamide, an antagonist of the androgen receptor. Furthermore when cells were co-transfected with a Cox-2 promoter or a 3xNF-kB luciferase reporter vector and a plasmid expressing the human androgen receptor, DHT treatment inhibited the increase of the luciferase activity observed with TNF{alpha}.

Conclusion. Dihydrotestosterone could positively regulate endothelial function through the control of the inflammatory response mediated by NF-kB in endothelial cells.


Key words: gene expression • endothelial function • signal transduction • hormones




This article has been cited by other articles:


Home page
Biol. Reprod.Home page
J. A. Rettew, Y. M. Huet-Hudson, and I. Marriott
Testosterone Reduces Macrophage Expression in the Mouse of Toll-Like Receptor 4, a Trigger for Inflammation and Innate Immunity
Biol Reprod, March 1, 2008; 78(3): 432 - 437.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
H. Liu, Y. Hu, R. W Simpson, and A. E Dear
Glucagon-like peptide-1 attenuates tumour necrosis factor-{alpha}-mediated induction of plasmogen activator inhibitor-1 expression
J. Endocrinol., January 1, 2008; 196(1): 57 - 65.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. P. Liu and M. Fukuoka
Sex Hormones as Novel Risk Biomarkers for Atherosclerosis in Peripheral Vascular Disease
J. Am. Coll. Cardiol., September 11, 2007; 50(11): 1077 - 1079.
[Full Text] [PDF]


Home page
JCOHome page
A. V. D'Amico, J. W. Denham, J. Crook, M.-H. Chen, S. Z. Goldhaber, D. S. Lamb, D. Joseph, K.-H. Tai, S. Malone, C. Ludgate, et al.
Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions
J. Clin. Oncol., June 10, 2007; 25(17): 2420 - 2425.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
E. Debing, E. Peeters, W. Duquet, K. Poppe, B. Velkeniers, and P. Van den Brande
Endogenous sex hormone levels in postmenopausal women undergoing carotid artery endarterectomy
Eur. J. Endocrinol., June 1, 2007; 156(6): 687 - 693.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society